Table 1 Total announced value of merger and acquisition deals with pharmaceutical and generic drug targets a,b,c
From: Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016
Sector | Global | United States | Global excluding the United States | |
|---|---|---|---|---|
All pharmaceuticals from 1995 to 2016 (in billions) | $1717.69 | $1035.57 | $682.12 | |
Generics from 1995 to 2016 | $160.30 | $101.71 | $58.59 | |
Generics as % of total | 9.3% | 9.8% | 8.6% | |
All pharmaceuticals | 2014 | $105.14 | $64.92 | $40.22 |
2015 | $250.32 | $191.20 | $59.12 | |
2016 | $126.28 | $97.43 | $28.85 | |
Generics | 2014 | $1.86 | $0.89 | $0.97 |
2015 | $33.56 | $26.66 | $6.90 | |
2016 | $44.01 | $42.95 | $1.06 | |
Generics as % of all pharmaceuticals | 2014 | 1.8% | 1.4% | 2.4% |
2015 | 13.4% | 14.0% | 11.6% | |
2016 | 34.9% | 44.1% | 3.7% | |